Search

everythinglearnresearchcommunity

for

Search:↓

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

A woman's hair grew back after she stopped taking the Parkinson's disease medication pramipexole.

A man developed a rash similar to pityriasis rubra pilaris after starting sorafenib for cancer, possibly due to the drug's effect on skin cells.

Combining PRP with other treatments can improve hair loss outcomes.

Platelet factor 4 slows down hair growth and could make hair loss treatments more effective if removed.

Blocking mTORC1 activity with rapamycin could help increase hair pigmentation and growth, potentially reversing gray hair.

The FDA did not approve certain drugs for prostate cancer prevention due to concerns about their effectiveness and potential risks.

Platelet-rich plasma may help hair follicle cells grow by affecting certain genes and pathways.

PRP injection for hair growth can cause reversible vision loss due to inflammatory optic neuropathy.

Finasteride reduces AML cell growth by inhibiting androgen receptors.

PRIDE syndrome includes skin and hair issues from cancer treatment with EGFR inhibitors.

PRP may help with aging and osteoarthritis, improving tissue repair and reducing surgery risk.

Hyaluronic acid filler can safely and effectively improve facial contour in Parry-Romberg Syndrome.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.

HPV infection is linked to better survival in advanced anal cancer, higher radiation doses improve survival, especially in HPV-negative patients, and prostaglandin E₂ pretreatment can protect mouse hair follicles from radiation damage.

SPET-085 effectively inhibits an enzyme linked to prostate issues, similar to finasteride.

Protein Kinase C shows promise for cancer treatment, but more research is needed to develop effective inhibitors.

The project developed and tested a method using plasma rich platelets to treat hair loss.

Platelets and their derivatives, like PRP, can help tissue regeneration, but need standardized safety protocols.

Pegylated interferon-alpha 2a can cause a rare nerve disorder, but early treatment can lead to full recovery.

Finasteride may help prevent prostate cancer.

Hedgehog pathway inhibitors can treat certain aggressive cancers but face limitations like resistance and side effects.

A new anti-baldness patch effectively treats hair loss by blocking enzymes linked to the condition.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

PRP may increase hair density but doesn't improve quality of life in breast cancer survivors with hair loss.

Placenderm® can improve hair health and promote hair regrowth.

Verteporfin reduces growth and stem cell traits in rat hair follicle cells by blocking the Hippo pathway.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.